| Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem … I Tzannou, A Papadopoulou, S Naik, K Leung, CA Martinez, CA Ramos, ... Journal of Clinical Oncology 35 (31), 3547, 2017 | 421 | 2017 |
| Anti-CD30 CAR-T cell therapy in relapsed and refractory Hodgkin lymphoma CA Ramos, NS Grover, AW Beaven, PD Lulla, MF Wu, A Ivanova, T Wang, ... Journal of clinical oncology 38 (32), 3794, 2020 | 288 | 2020 |
| Treatment of acute myeloid leukemia with T cells expressing chimeric antigen receptors directed to C-type lectin-like molecule 1 H Tashiro, T Sauer, T Shum, K Parikh, M Mamonkin, B Omer, RH Rouce, ... Molecular Therapy 25 (9), 2202-2213, 2017 | 129 | 2017 |
| CD7 CAR T cells for the therapy of acute myeloid leukemia D Gomes-Silva, E Atilla, PA Atilla, F Mo, H Tashiro, M Srinivasan, P Lulla, ... Molecular Therapy 27 (1), 272-280, 2019 | 119 | 2019 |
| CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation P Bajgain, S Tawinwung, L D’Elia, S Sukumaran, N Watanabe, V Hoyos, ... Journal for immunotherapy of cancer 6, 1-13, 2018 | 101 | 2018 |
| Tisagenlecleucel chimeric antigen receptor (CAR) T-cell therapy for adults with diffuse large B-cell lymphoma (DLBCL): real world experience from the Center for International … S Jaglowski, ZH Hu, Y Zhang, M Kamdar, M Ghosh, P Lulla, J Sasine, ... Blood 134, 766, 2019 | 93 | 2019 |
| Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma MA Kowalkowski, MP Mims, ES Amiran, P Lulla, EY Chiao PLoS One 8 (10), e77409, 2013 | 46 | 2013 |
| Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant PD Lulla, S Naik, S Vasileiou, I Tzannou, A Watanabe, M Kuvalekar, ... Blood, The Journal of the American Society of Hematology 137 (19), 2585-2597, 2021 | 44 | 2021 |
| T-cell therapy for lymphoma using nonengineered multiantigen-targeted T cells is safe and produces durable clinical effects S Vasileiou, PD Lulla, I Tzannou, A Watanabe, M Kuvalekar, WL Callejas, ... Journal of Clinical Oncology 39 (13), 1415, 2021 | 38 | 2021 |
| Posoleucel, an allogeneic, off-the-shelf multivirus-specific T-cell therapy, for the treatment of refractory viral infections in the post-HCT setting T Pfeiffer, I Tzannou, M Wu, C Ramos, G Sasa, C Martinez, P Lulla, ... Clinical Cancer Research 29 (2), 324-330, 2023 | 31 | 2023 |
| The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma PD Lulla, I Tzannou, S Vasileiou, G Carrum, CA Ramos, R Kamble, ... Science translational medicine 12 (554), eaaz3339, 2020 | 30 | 2020 |
| Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity A Torres Chavez, MK McKenna, E Canestrari, CT Dann, CA Ramos, ... Journal for immunotherapy of cancer 7, 1-15, 2019 | 29 | 2019 |
| Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis M Hamadani, AK Gopal, M Pasquini, S Kim, X Qiu, S Ahmed, A Lazaryan, ... Blood advances 6 (2), 486-494, 2022 | 28 | 2022 |
| Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections S Vasileiou, AM Turney, M Kuvalekar, SS Mukhi, A Watanabe, P Lulla, ... Haematologica 105 (1), 235, 2020 | 26 | 2020 |
| Immunologic profiling of human metapneumovirus for the development of targeted immunotherapy I Tzannou, SK Nicholas, P Lulla, PI Aguayo-Hiraldo, A Misra, CA Martinez, ... The Journal of Infectious Diseases 216 (6), 678-687, 2017 | 25 | 2017 |
| Retrospective review of extra-pulmonary small cell carcinoma and prognostic factors JE Brammer, P Lulla, GR Lynch International Journal of Clinical Oncology 19, 822-828, 2014 | 25 | 2014 |
| The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma PD Lulla, LQC Hill, CA Ramos, HE Heslop Clinical advances in hematology & oncology: H&O 16 (5), 375, 2018 | 23 | 2018 |
| Characterizing the cellular immune response to parainfluenza virus 3 PI Aguayo-Hiraldo, RJ Arasaratnam, I Tzannou, M Kuvalekar, P Lulla, ... The Journal of infectious diseases 216 (2), 153-161, 2017 | 20 | 2017 |
| Allogeneic NKT cells expressing a CD19-specific CAR in patients with relapsed or refractory B-cell malignancies: an interim analysis CA Ramos, AN Courtney, SN Robinson, O Dakhova, PD Lulla, R Kamble, ... Blood 138, 2819, 2021 | 19 | 2021 |
| Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL S Naik, S Vasileiou, I Tzannou, M Kuvalekar, A Watanabe, C Robertson, ... Blood, The Journal of the American Society of Hematology 139 (17), 2706-2711, 2022 | 18 | 2022 |
